OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
TRIP13 promotes lung cancer cell growth and metastasis through AKT/mTORC1/c-Myc signaling
Weiyang Cai, Wei Ni, Yin Jin, et al.
Cancer Biomarkers (2020) Vol. 30, Iss. 2, pp. 237-248
Closed Access | Times Cited: 26
Weiyang Cai, Wei Ni, Yin Jin, et al.
Cancer Biomarkers (2020) Vol. 30, Iss. 2, pp. 237-248
Closed Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
Xu‐Sheng Liu, Lu-Meng Zhou, Lingling Yuan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 91
Xu‐Sheng Liu, Lu-Meng Zhou, Lingling Yuan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 91
TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway
Zhang-Xian Xiao, Mingxi Li, Xiaoqian Zhang, et al.
Oncology Reports (2023) Vol. 49, Iss. 5
Open Access | Times Cited: 12
Zhang-Xian Xiao, Mingxi Li, Xiaoqian Zhang, et al.
Oncology Reports (2023) Vol. 49, Iss. 5
Open Access | Times Cited: 12
Targeting Thyroid Hormone Receptor Interacting Protein (TRIP13) for Cancer Therapy: A Promising Approach
Surya P. Singh, Krishnendu Goswami, Gopal Pathuri, et al.
DNA (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access
Surya P. Singh, Krishnendu Goswami, Gopal Pathuri, et al.
DNA (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access
α-hederin decreases the glycolysis level in intestinal epithelial cells via SNX10-mediated DEPDC5 degradation
Hui Feng, Jin Wang, Lihuiping Tao, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101301-101301
Open Access
Hui Feng, Jin Wang, Lihuiping Tao, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101301-101301
Open Access
Thyroid hormone receptor interacting protein 13 is associated with prognosis and immunotherapy efficacy in human cancers: a pan-cancer analysis
Suli Zheng, Hongyi Wang, Yingyi Wang
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Suli Zheng, Hongyi Wang, Yingyi Wang
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Unveiling the Role of Mechanistic Target of Rapamycin Kinase (MTOR) Signaling in Cancer Progression and the Emergence of MTOR Inhibitors as Therapeutic Strategies
Devashish Mehta, Kajal Rajput, Dolly Jain, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3758-3779
Closed Access | Times Cited: 3
Devashish Mehta, Kajal Rajput, Dolly Jain, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3758-3779
Closed Access | Times Cited: 3
Xiaoying Liu, Xin Shen, Jing Zhang
Environmental Toxicology (2021) Vol. 36, Iss. 9, pp. 1829-1840
Closed Access | Times Cited: 18
TRIP13 Activates Glycolysis to Promote Cell Stemness and Strengthen Doxorubicin Resistance of Colorectal Cancer Cells
Guangyi Liu, Huan Wang, Rui Ran, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 22, pp. 3397-3411
Closed Access | Times Cited: 2
Guangyi Liu, Huan Wang, Rui Ran, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 22, pp. 3397-3411
Closed Access | Times Cited: 2
Targeting TRIP13 for overcoming anticancer drug resistance (Review)
Liwen Zhao, Siyu Ye, Shengnan Jing, et al.
Oncology Reports (2023) Vol. 50, Iss. 5
Open Access | Times Cited: 6
Liwen Zhao, Siyu Ye, Shengnan Jing, et al.
Oncology Reports (2023) Vol. 50, Iss. 5
Open Access | Times Cited: 6
Shuaikang Chang, Wenqin Xiao, Yongsheng Xie, et al.
Cancer Medicine (2023) Vol. 12, Iss. 23, pp. 21321-21334
Open Access | Times Cited: 5
A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients
Qiang Guo, Kai Li, Ni Jiang, et al.
Aging (2023) Vol. 15, Iss. 18, pp. 9633-9660
Open Access | Times Cited: 4
Qiang Guo, Kai Li, Ni Jiang, et al.
Aging (2023) Vol. 15, Iss. 18, pp. 9633-9660
Open Access | Times Cited: 4
High expression of TRIP13 is associated with tumor progression in H. pylori infection induced gastric cancer
Longxiang Wu, Qiu Xue, Xiaochun Xia
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2024) Vol. 828, pp. 111854-111854
Closed Access | Times Cited: 1
Longxiang Wu, Qiu Xue, Xiaochun Xia
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2024) Vol. 828, pp. 111854-111854
Closed Access | Times Cited: 1
TRIP13 Plays an Important Role in the Sensitivity of Leukemia Cell Response to Sulforaphane Therapy
Lei Liu, Baixue Liao, Ruiling Fan, et al.
ACS Omega (2024) Vol. 9, Iss. 24, pp. 26628-26640
Open Access | Times Cited: 1
Lei Liu, Baixue Liao, Ruiling Fan, et al.
ACS Omega (2024) Vol. 9, Iss. 24, pp. 26628-26640
Open Access | Times Cited: 1
TRIP13 − a potential drug target in cancer pharmacotherapy
Samuel J. Bunu, Haiyan Cai, Leyun Wu, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107650-107650
Closed Access | Times Cited: 1
Samuel J. Bunu, Haiyan Cai, Leyun Wu, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107650-107650
Closed Access | Times Cited: 1
Role of TRIP13 in human cancer development
Chaohu Chen, Li Pan, Guangrui Fan, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Chaohu Chen, Li Pan, Guangrui Fan, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
Deciphering the enigmatic crosstalk between prostate cancer and Alzheimer's disease: A current update on molecular mechanisms and combination therapy
Nitesh Kumar Poddar, Disha Agarwal, Yamini Agrawal, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 11, pp. 166524-166524
Open Access | Times Cited: 7
Nitesh Kumar Poddar, Disha Agarwal, Yamini Agrawal, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 11, pp. 166524-166524
Open Access | Times Cited: 7
Common pathways and functional profiles reveal underlying patterns in Breast, Kidney and Lung cancers
Sergio Romera-Giner, Zoraida Andreu Martínez, Francisco García‐García, et al.
Biology Direct (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Sergio Romera-Giner, Zoraida Andreu Martínez, Francisco García‐García, et al.
Biology Direct (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Identification of Tumor-Suppressive miR-139-3p-Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma
Yoko Hagihara, Yuya Tomioka, Takayuki Suetsugu, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5571-5571
Open Access | Times Cited: 3
Yoko Hagihara, Yuya Tomioka, Takayuki Suetsugu, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5571-5571
Open Access | Times Cited: 3
Identification of genetically predicted DNA methylation markers associated with non–small cell lung cancer risk among 34,964 cases and 448,579 controls
Xiaoyu Zhao, Meiqi Yang, Jingyi Fan, et al.
Cancer (2023) Vol. 130, Iss. 6, pp. 913-926
Open Access | Times Cited: 3
Xiaoyu Zhao, Meiqi Yang, Jingyi Fan, et al.
Cancer (2023) Vol. 130, Iss. 6, pp. 913-926
Open Access | Times Cited: 3
[TRIP13 Enhances Radioresistance of Lung Adenocarcinoma Cells
through the Homologous Recombination Pathway].
Shutong Ge, Runchuan Gu, Xiongtao Yang, et al.
PubMed (2024) Vol. 27, Iss. 1, pp. 1-12
Closed Access
Shutong Ge, Runchuan Gu, Xiongtao Yang, et al.
PubMed (2024) Vol. 27, Iss. 1, pp. 1-12
Closed Access
Hyper-methylation and DNMT3A mediated LTC4S downregulation promoted lung adenocarcinoma tumorigenesis via mTORC1 signaling pathway
Yang Ren, Peng Zhang, Liqun Li, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33203-e33203
Open Access
Yang Ren, Peng Zhang, Liqun Li, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33203-e33203
Open Access
A Bruton tyrosine kinase inhibitor-resistance gene signature predicts prognosis and identifies TRIP13 as a potential therapeutic target in diffuse large B-cell lymphoma
Yangyang Ding, Keke Huang, Cheng Sun, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Yangyang Ding, Keke Huang, Cheng Sun, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Thyroid Hormone Receptor Interacting Protein 13 Is Associated with Prognosis and Immunotherapy Efficacy in Human Cancers: A Pan-cancer Analysis
Suli Zheng, Hongyi Wang, Yingyi Wang
Research Square (Research Square) (2024)
Open Access
Suli Zheng, Hongyi Wang, Yingyi Wang
Research Square (Research Square) (2024)
Open Access
Damage-associated Molecular Patterns Related Score (DAMPscore) Identifies Subtypes of Hepatocellular Carcinoma with Distinct Prognosis and Treatment Sensitivity
Zhen Zhang, Yan Jiang, Xianglin Hu, et al.
Research Square (Research Square) (2024)
Open Access
Zhen Zhang, Yan Jiang, Xianglin Hu, et al.
Research Square (Research Square) (2024)
Open Access
Role of mTORC1 Signaling in Regulating the Immune Function of Granulocytes in Teleost Fish
Jiafeng Cao, Weiguang Kong, Gaofeng Cheng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13745-13745
Open Access
Jiafeng Cao, Weiguang Kong, Gaofeng Cheng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13745-13745
Open Access
